Yabao Pharmaceutical Group Co. Ltd. Class ASSE: 600351

Announcement on Correction of Report for Q3 2024

Oct 26, 2024 · Issued by Yabao Pharmaceutical Group Co. Ltd. Class A via Shanghai Stock Exchange

Announcement on Correction of Report for Q3 2024

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment